Development of an effective contemporary trivalent avian influenza vaccine against circulating H5N1, H5N8, and H9N2 in Egypt

被引:9
|
作者
Gomaa, Mokhtar Rizk [1 ]
Khalil, Ahmed Ali [2 ]
Kandeil, Ahmed [1 ]
Sabir, Jamal S. M. [3 ,4 ]
Kayed, Ahmed [1 ]
Moatasim, Yassmin [1 ]
El Saied, Marwa F. [5 ]
El-Safty, Mounir M. [5 ]
Kayali, Ghazi [6 ,7 ]
Ali, Mohamed A. [1 ,3 ]
机构
[1] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Water Pollut Res Dept, Cairo 12622, Egypt
[2] VSVRI, Cairo 11381, Egypt
[3] King Abdulaziz Univ, Ctr Excellence Bionanosci Res, Jeddah 21589, Saudi Arabia
[4] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Biotechnol Res Grp, Jeddah 21589, Saudi Arabia
[5] Cent Lab Evaluat Vet Biol, Cairo 11381, Egypt
[6] Univ Texas Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA
[7] Human Link, Baabda 1109, Lebanon
基金
美国国家卫生研究院;
关键词
avian influenza; trivalent; vaccine; Egypt; MULTIPLE INTRODUCTIONS; VIRUSES; POULTRY; OUTBREAKS;
D O I
10.3382/ps/pez385
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Low pathogenicity avian influenza (LPAI) H9N2, highly pathogenic avian influenza (HPAI) H5N1, and H5N8 circulate in Egyptian poultry and cause veterinary and public health burdens. In response, AIV vaccines are commonly used. The main objective of this study was to develop a broad, cross-protective, trivalent vaccine based on circulating AIVs in Egypt. We generated highly replicating avirulent AIVs, H5N1, and H5N8, to be used in combination with H9N2 strain for the generation of an inactivated vaccine. Immunogenicity and protective efficacy of this vaccine were tested. Results showed that a single immunization dose enhanced humoral immune responses giving full protection against challenges with LPAI H9N2, HPAI H5N1, and H5N8 viruses. This efficacious vaccine will reduce the cost of vaccination for poultry growers and is expected to be effective in the field as it is based on contemporary viruses currently in circulation among Egyptian poultry.
引用
收藏
页码:6289 / 6295
页数:7
相关论文
共 50 条
  • [11] Experimental infection of mandarin duck with highly pathogenic avian influenza A (H5N8 and H5N1) viruses
    Kang, Hyun-Mi
    Lee, Eun-Kyoung
    Song, Byung-Min
    Heo, Gyeong-Beom
    Jung, Joojin
    Jang, Il
    Bae, You-Chan
    Jung, Suk Chan
    Lee, Youn-Jeong
    VETERINARY MICROBIOLOGY, 2017, 198 : 59 - 63
  • [12] Challenge for One Health: Co-Circulation of Zoonotic H5N1 and H9N2 Avian Influenza Viruses in Egypt
    Kim, Shin-Hee
    VIRUSES-BASEL, 2018, 10 (03):
  • [13] H9N2 influenza A virus circulates in H5N1 endemically infected poultry population in Egypt
    Monne, Isabella
    Hussein, Hussein A.
    Fusaro, Alice
    Valastro, Viviana
    Hamoud, Mohamed M.
    Khalefa, Rabab A.
    Dardir, Shahin N.
    Radwan, Moustafa I.
    Capua, Ilaria
    Cattoli, Giovanni
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (03) : 240 - 243
  • [14] Review analysis and impact of co-circulating H5N1 and H9N2 avian influenza viruses in Bangladesh
    Parvin, Rokshana
    Begum, Jahan Ara
    Nooruzzaman, Mohammed
    Chowdhury, Emdadul Haque
    Islam, Mohammad Rafiqul
    Vahlenkamp, Thomas W.
    EPIDEMIOLOGY AND INFECTION, 2018, 146 (10) : 1259 - 1266
  • [15] Experimental infection of Clades 2.2.1.2 (H5N1) and 2.3.4.4b (H5N8) of highly pathogenic avian influenza virus infection in commercial broilers
    Sultan, Hesham A.
    Talaat, Shaimaa
    Amer, Sameh Abdel-Moez
    Tantawy, Laila
    El-Zanaty, Abd Elfattah I.
    Albadrani, Ghadeer M.
    Al-Ghadi, Muath Q.
    Abdel-Daim, Mohamed M.
    Elfeil, Wael K.
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2024, 113
  • [16] Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both Highly Pathogenic H5N1 and H9N2 Influenza Viruses
    Nguyen Tai Nang
    Song, Byung Min
    Kang, Young Myong
    Kim, Heui Man
    Kim, Hyun Soo
    Seo, Sang Heui
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (02) : 120 - 131
  • [17] Generation of a reassortant avian influenza virus H5N2 vaccine strain capable of protecting chickens against infection with Egyptian H5N1 and H9N2 viruses
    Kandeil, Ahmed
    Moatasim, Yassmin
    Gomaa, Mokhtar R.
    Shehata, Mahmoud M.
    El-Shesheny, Rabeh
    Barakat, Ahmed
    Webby, Richard J.
    Ali, Mohamed A.
    Kayali, Ghazi
    VACCINE, 2016, 34 (02) : 218 - 224
  • [18] Do commercial avian influenza H5 vaccines induce cross-reactive antibodies against contemporary H5N1 viruses in Egypt?
    Kayali, G.
    Kandeil, A.
    El-Shesheny, R.
    Kayed, A. S.
    Gomaa, M. R.
    Kutkat, M. A.
    Debeauchamp, J.
    Mckenzie, P. P.
    Webster, R. G.
    Webby, R. J.
    Ali, M. A.
    POULTRY SCIENCE, 2013, 92 (01) : 114 - 118
  • [19] A replication-deficient H9N2 influenza virus carrying H5 hemagglutinin conferred protection against H9N2 and H5N1 influenza viruses in mice
    Ren, Weigang
    Pei, Shuli
    Jiang, Wenming
    Zhao, Meixia
    Jiang, Le
    Liu, Honggang
    Yi, Yongxiang
    Hui, Mizhou
    Li, Junwei
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [20] Inactivated H5 antigens of H5N8 protect chickens from lethal infections by the highly pathogenic H5N8 and H5N6 avian influenza viruses
    Jin, Myongha
    Jang, Yunyueng
    Seo, Taehyun
    Seo, Sang Heui
    JOURNAL OF VETERINARY RESEARCH, 2018, 62 (04) : 413 - 420